{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:55:32Z","timestamp":1779378932827,"version":"3.53.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jval.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T20:03:31Z","timestamp":1558037011000},"page":"863-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data"],"prefix":"10.1016","volume":"22","author":[{"given":"Jian","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongru","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jval.2019.02.001_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jval.2019.02.001_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jval.2019.02.001_bib3","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1503\/cmaj.111173","article-title":"Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies","volume":"184","author":"Marzona","year":"2012","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.jval.2019.02.001_bib4","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.jval.2019.02.001_bib5","first-page":"1360","article-title":"Guidelines for the management of atrial\u00a0fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jval.2019.02.001_bib6","first-page":"50","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"23","key":"10.1016\/j.jval.2019.02.001_bib7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"8a","key":"10.1016\/j.jval.2019.02.001_bib8","doi-asserted-by":"crossref","first-page":"2n","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jval.2019.02.001_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A\u00a0population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"issue":"23","key":"10.1016\/j.jval.2019.02.001_bib10","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jval.2019.02.001_bib11","first-page":"277","article-title":"Cognitive function and anticoagulation control in patients with atrial fibrillation","volume":"3","author":"Flaker","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jval.2019.02.001_bib12","first-page":"491","article-title":"An epidemiological survey of atrial fibrillation in China [in Chinese]","volume":"43","author":"Zhou","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"9","key":"10.1016\/j.jval.2019.02.001_bib13","first-page":"709","article-title":"Prevalence of atrial fibrillation in China and its risk factors","volume":"26","author":"Li","year":"2013","journal-title":"Biomed Environ Sci"},{"issue":"18","key":"10.1016\/j.jval.2019.02.001_bib14","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jval.2019.02.001_bib15","first-page":"5","article-title":"The illness burden brought by atrial fibrillation in China","author":"Zhang","year":"2013","journal-title":"Chin Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2019.02.001_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jce.12275","article-title":"Catheter ablation of atrial fibrillation: to freeze, or not to freeze, that is the question","volume":"25","author":"Fitzgerald","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"23","key":"10.1016\/j.jval.2019.02.001_bib17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jval.2019.02.001_bib19","series-title":"China Guidelines for Pharmacoeconomic Evaluations and Manual (Version 2015)","author":"Liu","year":"2015"},{"issue":"2","key":"10.1016\/j.jval.2019.02.001_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2176\/nmc.52.175","article-title":"Medical care for chronic-phase stroke in Japan","volume":"52","author":"Hattori","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib24","first-page":"362","article-title":"Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation","volume":"2","author":"Reynolds","year":"2009","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jval.2019.02.001_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jval.2019.02.001_bib27","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jval.2019.02.001_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jval.2019.02.001_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vhri.2018.01.009","article-title":"Recent pricing negotiations on innovative medicines pilot in China: experiences, implications, and suggestions","volume":"15","author":"Li","year":"2018","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","author":"Calkins","year":"2012","journal-title":"Heart Rhythm"},{"issue":"38","key":"10.1016\/j.jval.2019.02.001_bib31","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","article-title":"Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial","volume":"37","author":"Kuck","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2019.02.001_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijcard.2014.12.002","article-title":"The long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation: a meta-analysis","volume":"181","author":"Cheng","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jval.2019.02.001_bib33","doi-asserted-by":"crossref","first-page":"e90323","DOI":"10.1371\/journal.pone.0090323","article-title":"Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysis","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib34","first-page":"336","article-title":"Cryoballoon ablation versus remote magnetic navigation ablation in patients with paroxysmal atrial fibrillation: a prospective controlled study","volume":"20","author":"Jin","year":"2016","journal-title":"Chin J Cardiac Arrhyth"},{"key":"10.1016\/j.jval.2019.02.001_bib35","first-page":"262809","article-title":"Cost-effectiveness of catheter ablation for rhythm control of atrial fibrillation","volume":"2013","author":"Blackhouse","year":"2013","journal-title":"Int J Vasc Med"},{"issue":"7","key":"10.1016\/j.jval.2019.02.001_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/hrt.2008.147165","article-title":"Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom","volume":"95","author":"McKenna","year":"2009","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.jval.2019.02.001_bib37","first-page":"89","article-title":"A\u00a0cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS2 score in Japan","volume":"69","author":"Kimura","year":"2017","journal-title":"J\u00a0Cardiol"},{"issue":"5","key":"10.1016\/j.jval.2019.02.001_bib38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/europace\/eut380","article-title":"Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation","volume":"16","author":"Reynolds","year":"2014","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.jval.2019.02.001_bib39","first-page":"959","article-title":"Cost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies","volume":"19","author":"Hunter","year":"2016","journal-title":"J\u00a0Med Econ"},{"issue":"8","key":"10.1016\/j.jval.2019.02.001_bib40","article-title":"The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial","volume":"6","author":"Chun","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jval.2019.02.001_bib41","doi-asserted-by":"crossref","first-page":"5106127","DOI":"10.1155\/2016\/5106127","article-title":"Comparison between first- and second-generation cryoballoon for paroxysmal atrial fibrillation ablation","volume":"2016","author":"Conti","year":"2016","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"10.1016\/j.jval.2019.02.001_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10840-015-0075-4","article-title":"Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence","volume":"45","author":"Pandya","year":"2016","journal-title":"J\u00a0Interv Card Electrophysiol"},{"issue":"9","key":"10.1016\/j.jval.2019.02.001_bib43","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1590\/1414-431x20176409","article-title":"Comparative efficacy and safety of contact force-sensing catheter and second-generation cryoballoon ablation for atrial fibrillation: a meta-analysis","volume":"50","author":"Zhou","year":"2017","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.jval.2019.02.001_bib44","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519301020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519301020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:16:15Z","timestamp":1761095775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519301020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1098301519301020"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.02.001","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}